A KIF20A-Based Thermosensitive Hydrogel Vaccine Effectively Potentiates Immune Checkpoint Blockade Therapy for Hepatocellular Carcinoma

Researchers confirmed kinesin family member 20A (KIF20A) as a promising immunogenic antigen through transcriptomic mRNA sequencing analysis in the context of HCC.